Legal & General Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.7M | Buy |
|
|||||
|
2025
Q1 | $20.8M | Buy |
|
|||||
|
2024
Q4 | $15.9M | Sell |
|
|||||
|
2024
Q3 | $15.1M | Sell |
|
|||||
|
2024
Q2 | $26.8M | Sell |
|
|||||
|
2024
Q1 | $43.6M | Sell |
|
|||||
|
2023
Q4 | $48.4M | Sell |
|
|||||
|
2023
Q3 | $53.2M | Sell |
|
|||||
|
2023
Q2 | $54.3M | Sell |
|
|||||
|
2023
Q1 | $68.3M | Sell |
|
|||||
|
2022
Q4 | $76.6M | Sell |
|
|||||
|
2022
Q3 | $65.4M | Sell |
|
|||||
|
2022
Q2 | $76.8M | Sell |
|
|||||
|
2022
Q1 | $76.8M | Buy |
|
|||||
|
2021
Q4 | $57.1M | Sell |
|
|||||
|
2021
Q3 | $59.2M | Sell |
|
|||||
|
2021
Q2 | $84.6M | Buy |
|
|||||
|
2021
Q1 | $72M | Sell |
|
|||||
|
2020
Q4 | $73.4M | Sell |
|
|||||
|
2020
Q3 | $64.3M | Buy |
|
|||||
|
2020
Q2 | $44M | Buy |
|
|||||
|
2020
Q1 | $35.3M | Buy |
|
|||||
|
2019
Q4 | $51.4M | Buy |
|
|||||
|
2019
Q3 | $42.8M | Buy |
|
|||||
|
2019
Q2 | $46.9M | Sell |
|
|||||
|
2019
Q1 | $47.9M | Buy |
|
|||||
|
2018
Q4 | $32.5M | Buy |
|
|||||
|
2018
Q3 | $40.6M | Buy |
|
|||||
|
2018
Q2 | $41.6M | Buy |
|
|||||
|
2018
Q1 | $35.8M | Sell |
|
|||||
|
2017
Q4 | $31.9M | Buy |
|
|||||
|
2017
Q3 | $34.3M | Buy |
|
|||||
|
2017
Q2 | $36.1M | Buy |
|
|||||
|
2017
Q1 | $32.8M | Buy |
|
|||||
|
2016
Q4 | $24.3M | Buy |
|